A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

493

Participants

Timeline

Start Date

April 10, 2015

Primary Completion Date

March 16, 2018

Study Completion Date

March 16, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Placebo

Placebo tablets

DRUG

Vortioxetine

Vortioxetine tablets

Trial Locations (47)

Unknown

Nagoya

Nagareyama

Noda

Iizuka

Kitakyushu

Kurume

Kōriyama

Shirakawa

Sapporo

Ashiya

Kanazawa

Kawasaki

Yokohama

Yokosuka

Kurashiki

Kadoma

Kita-ku

Sakai

Sayama

Karatsu

Kawagoe

Kusatsu

Anan

Arakawa-ku

Chiyoda-ku

Hachiōji

Itabashi-ku

Katsushika-ku

Koto-ku

Meguro-ku

Minato-ku

Mitaka

Musashino

Nakano-ku

Setagaya-ku

Shibuya-ku

Shinagawa-ku

Shinjuku-ku

Suginami-ku

Taito-ku

Toshima-ku

Kofu

Fukuoka

Hiroshima

Kumamoto

Okayama

Saitama

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY